Resistance in Campylobacter species: Increased resistance to fluoroquinolones and seasonal variation

Clinical Infectious Diseases

Volumn 29, Issue 4, 1999, Pages 845-848

  Talsma, E ^a,b   Goettsch, W G ^a,b   Nieste, H L J ^a,b   Schrijnemakers, P M ^a,b   Sprenger, M J W ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CAMPYLOBACTER; CHILD; DATA ANALYSIS; DEMOGRAPHY; DISEASE CONTROL; FECES ANALYSIS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SEASONAL VARIATION; WINTER;

EID: 0033509010     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520447     Document Type: Article

References (18)

1. Endtz HP, Ruijs GJ, Klingeren van B, Jansen WH, Reyden van der T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 1991;27:199-208.
2. Endtz HP, Broeren M, Mouton RP. In vitro susceptibility of quinoloneresistant Campylobacter jejuni to new macrolide antibiotics. Eur J Clin Microbiol Infect Dis 1993:12:48-50.
3. Endtz HP, Mouton RP, van der Reyden T, Ruijs GJ, Biever M, Klingeren van B. Fluoroquinolone resistance in Campylobacter species isolaled from human stools and poultry products [letter]. Lancet 1990;335:787.
4. Harnett N, McLeod S, Yong YA, Hewitt C, Vearncombe M, Krishnan C. Quinolone resistance in clinical strains of Campylobacter jejuni and Campylobacter coli [letter]. J Antimicrob Chemother 1995;36:269-70.
5. McIntyre M, Lyons M. Resistance to ciprofloxacin in Campylobacter species [letter]. Lancet 1993;341:188.
6. Gaunt PN, Piddock LJ. Ciprofloxacin resistant Campylobacter species in humans: an epidemiological and laboratory study. J Antimicrob Chemother 1996;37:747-57.
7. Sjogren E, Kaijser B, Werner M. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother 1992;36:2847-9.
8. Bowler I, Day D. Emerging quinolone resistance in campylobacters. Lancet 1992;340:245.
9. Jacobs-Reitsma WF, Koenraad PMFJ, Bolder NM, Mulder RWAW. In vitro susceptibility of Campylobacter and Salmonella isolates from broilers to quinolones, ampicillin, tetracycline, and crythromycin. Vet Q 1994;16:206 8.
10. Sprenger MJW, Schrijnemakers PM, Wijgergangs LM. ISIS: Infectious Disease Surveillance Information System. Nederlands Tijdschrift voor Medische Microbiologie 1998;6:58-63.
11. Neo-sensitabs susceptibility testing, 10th ed. Taastrup, Denmark: Rosco Diagnostica, 1998.
12. Baquero F. European standards for antibiotic susceptibility testing: towards a theoretical consensus. Eur J Clin Microbiol Infect Dis 1990;9:492-5.
13. SAS Institute, Inc. Statistical Analyses System. Version 6.12. Cary, NC: SAS Institute, 1989-1996.
14. Microsoft Corporation, Inc. Microsoft Excel, version 5.0c. Portland, OR: Microsoft, 1995-1997.
15. Velazquez JB, Jimenez A, Chomon B, Villa TG. Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 1995;35:173-8.
16. Gomez-Garces JL, Cogollos R, Alos JL. Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents. Antimicrob Agents Chemother 1995;39:542-4.
17. Sanchez R, Fernandez-Baca V, Diaz MD, Munoz P, Rodriguez-Creixems M, Bouza E. Evolution of susceptibilities of Campytobacter species to quinolones and macrolides. Antimicrob Agents Chemother 1994;38:1879-82.
18. Taylor DE, Courvalin P. Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother 1988;32:1107-12.